Back
Expedia Group, Inc. Vs. Regencell Bioscience Holdings Ltd. Industry Stock Comparison
Buy
88
EXPE
Expedia Group, Inc.
Last Price:
$301.37
Seasonality Move:
2.58%
Buy
70
RGC
Regencell Bioscience Holdings Ltd.
Last Price:
$41.51
Seasonality Move:
69.73%
Buy
88
Expedia Group, Inc. (EXPE)
is a Buy
Is Expedia Group, Inc. a Buy, Sell or Hold?
-
The current Expedia Group, Inc. [EXPE] share price is $301.31. The Score for EXPE is 88, which is 76% above its historic median score of 50, and infers lower risk than normal.
-
EXPE is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
70
Regencell Bioscience Holdings Ltd. (RGC)
is a Buy
Is Regencell Bioscience Holdings Ltd. a Buy, Sell or Hold?
-
The current Regencell Bioscience Holdings Ltd. [RGC] share price is $52.88. The Score for RGC is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
-
RGC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EXPE Stock Price Chart
What is Expedia Group, Inc.'s stock price today?
-
The Expedia Group, Inc. share price today is $301.31Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EXPE is experiencing buying pressure, which is a positive indicator for future bullish movement.
RGC Stock Price Chart
What is Regencell Bioscience Holdings Ltd.'s stock price today?
-
The Regencell Bioscience Holdings Ltd. share price today is $52.88Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RGC is experiencing selling pressure, which indicates risk of future bearish movement.
EXPE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.41 | Buy |
| Relative Strength Index (14 RSI): | 71.52 | Buy |
| Chaikin Money Flow: | 1184388 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (270.07 - 293.15) | Buy |
| Bollinger Bands (100): | (211.02 - 268.96) | Buy |
RGC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.21 | Buy |
| Relative Strength Index (14 RSI): | 87.06 | Buy |
| Chaikin Money Flow: | 2558033 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
EXPE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 290.41 | Buy |
| 20-day SMA: | 286.52 | Buy |
| 50-day SMA: | 262.68 | Buy |
| 200-day SMA: | 205.23 | Buy |
| 8-day EMA: | 292.73 | Buy |
| 20-day EMA: | 284.59 | Buy |
| 50-day EMA: | 266.14 | Buy |
| 200-day EMA: | 219.2 | Buy |
RGC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.75 | Buy |
| 20-day SMA: | 22.49 | Buy |
| 50-day SMA: | 17.26 | Buy |
| 200-day SMA: | 14.27 | Buy |
| 8-day EMA: | 31.19 | Buy |
| 20-day EMA: | 24.47 | Buy |
| 50-day EMA: | 19.59 | Buy |
| 200-day EMA: | 13.98 | Buy |
Expedia Group, Inc. Earnings Growth & EXPE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.65 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.69 per share, and an increase next year of $3.69 per share.
Regencell Bioscience Holdings Ltd. Earnings Growth & RGC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Expedia Group, Inc. Technical Analysis
| Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 29 | 30 | 31 | 02 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Regencell Bioscience Holdings Ltd. Technical Analysis
| Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 29 | 30 | 31 | 02 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||